Sign up to save your podcasts
Or
Share Stage IIIA NSCLC: Advantages of Neoadjuvant Therapy
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Stage IIIA NSCLC: Advantages of Neoadjuvant Therapy
Dr. Mark Kris discusses the risks and benefits of using neoadjuvant therapy vs chemoradiation preoperatively for patients with stage IIIA lung cancer.
View all episodes
By MedscapeDr. Mark Kris discusses the risks and benefits of using neoadjuvant therapy vs chemoradiation preoperatively for patients with stage IIIA lung cancer.